We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+31.05%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$3.42B
AUM Growth
+$931M
(+37%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
88
New
10
Increased
35
Reduced
24
Closed
6
Top Buys
| 1 |
FOLD
Amicus Therapeutics
FOLD
|
+$138M |
| 2 |
Biogen
BIIB
|
+$52.1M |
| 3 |
CELG
Celgene Corp
CELG
|
+$46.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$37.1M |
| 5 |
Align Technology
ALGN
|
+$34.2M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$114M |
| 2 |
Cigna
CI
|
+$50M |
| 3 |
Medtronic
MDT
|
+$38.2M |
| 4 |
CVS Health
CVS
|
+$25.1M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$20.7M |
Sector Composition
| 1 | Healthcare | 94.57% |
| 2 | Financials | 2.23% |
| 3 | Energy | 0.01% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $267M | 7.83% |
10,970,518
-5,488,610
| -33% | -$114M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $267M | 7.81% |
19,616,062
+11,292,845
| +136% | +$138M |
|
3
Fate Therapeutics
FATE
$346M
| $182M | 5.33% |
10,359,666
| – | – |
|
4
Atara Biotherapeutics
ATRA
$77.1M
| $178M | 5.22% |
179,417
+2,832
| +2% | +$2.63M |
|
5
argenx
ARGX
$54.1B
| $127M | 3.72% |
1,019,061
+58,100
| +6% | +$6.83M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $113M | 3.31% |
4,563,929
+503,400
| +12% | +$12.6M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals
ALDR
| $113M | 3.29% |
8,244,896
+1,739,130
| +27% | +$22.5M |
|
8
Wave Life Sciences
WVE
$1.14B
| $110M | 3.22% |
2,831,507
+593,900
| +27% | +$24.1M |
|
|
BOLD
9
DELISTED
Audentes Therapeutics, Inc
BOLD
| $107M | 3.12% |
2,735,267
+433,600
| +19% | +$12.4M |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $95.3M | 2.79% |
7,694,020
+1,056,742
| +16% | +$11.8M |
|
11
Xencor
XNCR
$1.11B
| $94.3M | 2.76% |
3,036,603
-48,100
| -2% | -$1.6M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $90.4M | 2.64% |
2,874,100
+336,800
| +13% | +$10.2M |
|
13
InflaRx
IFRX
$300M
| $82.5M | 2.41% |
2,182,638
+147,238
| +7% | +$5.49M |
|
14
Regenxbio
RGNX
$631M
| $81.4M | 2.38% |
1,420,342
+65,600
| +5% | +$3.25M |
|
15
uniQure
QURE
$2.81B
| $78M | 2.28% |
1,307,522
+4,100
| +0.3% | +$183K |
|
|
16
Bristol-Myers Squibb
BMY
$119B
| $76.3M | 2.23% |
1,599,700
+745,000
| +87% | +$37.1M |
|
17
eHealth
EHTH
$48.9M
| $76.2M | 2.23% |
1,222,405
+131,010
| +12% | +$7.22M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $74.3M | 2.17% |
1,834,410
+135,762
| +8% | +$5.49M |
|
19
LivaNova
LIVN
$4.4B
| $56.7M | 1.66% |
582,687
+67,700
| +13% | +$6.32M |
|
20
Tandem Diabetes Care
TNDM
$1.06B
| $54.4M | 1.59% |
855,932
-183,818
| -18% | -$9.66M |
|
21
Elevance Health
ELV
$84.4B
| $50.7M | 1.48% |
176,700
+61,200
| +53% | +$17.7M |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $50.5M | 1.48% |
+535,700
| New | +$46.9M |
|
23
Teva Pharmaceuticals
TEVA
$36.9B
| $49.3M | 1.44% |
3,147,000
+1,318,100
| +72% | +$23.2M |
|
24
Penumbra
PEN
$12.5B
| $47.5M | 1.39% |
323,170
+177,562
| +122% | +$25.4M |
|
|
25
Align Technology
ALGN
$12.9B
| $40.7M | 1.19% |
+143,200
| New | +$34.2M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO